HEPATITIS B VACCINATION COVERAGE AND DETERMINANTS AMONG HEALTHCARE WORKERS IN A TERTIARY HOSPITAL IN SOUTHEAST
Main Article Content
Abstract
Healthcare workers (HCWs) face the greatest risk of exposure to a blood-borne infection from hepatitis B virus (HBV). HCWs at a tertiary hospital were surveyed to determine their vaccination status against HBV and the reasons that may have affected their decision to get vaccinated. The research design used was descriptive cross-sectional. Healthcare workers in Alex Ekwueme Federal University Teaching Hospital Abakaliki (AEFUTHA), Ebonyi State, Nigeria, were randomly recruited from across the cadre to participate in the study. The information was gathered by use of a self-administered, standardized, and pre-tested questionnaire. SPSS version 26 was used for both descriptive and inferential data analyses. In all, 418 HCWs took part in the research. The average age was 35.5 ± 9.1; the vast majority were nurses (53.0%); and 60.3% had been in the workforce for more than 5 years. About 315 (75.4%) respondents had good knowledge of HBV infection, while 290 (69.4%) had good knowledge of the HBV vaccine. Only about 131 (31%) had received a complete vaccination of the HBV vaccine, while 45 (10.8%) had incomplete vaccinations. Vaccine hesitancy was cited by 42 (10%) of respondents, and vaccine accessibility issues were cited by 35 (8.4%). This study showed that despite HCWs in AEFUTHA having a solid understanding of the virus and its vaccine, they are not taking advantage of that information by getting vaccinated against HBV. HCWs need to be informed about the dangers of contracting HBV and other blood-borne diseases through health education programs.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Aaron, D., Nagu, T. J., Rwegasha, J., & Komba, E. (2017). Hepatitis B vaccination coverage among healthcare workers at a national hospital in Tanzania: How much, who and why? BMC Infectious Diseases, 17(1), 1–7. https://doi.org/10.1186/s12879-017-2893-8
Abdela, A., Woldu, B., Haile, K., Mathewos, B., & Deressa, T. (2016). Assessment of knowledge, attitudes and practices toward prevention of hepatitis B virus infection among students of medicine and health sciences in Northwest Ethiopia. BMC Research Notes, 9, 410. https://doi.org/10.1186/s13104-016-2216-y
Abebaw, T. A., Aderaw, Z., & Gebremichael, B. (2017). Hepatitis B virus vaccination status and associated factors among health care workers in Shashemene Zonal Town, Ethiopia: A cross-sectional study. BMC Research Notes, 10(1), 260. https://doi.org/10.1186/s13104-017-2582-0
Abeje, G., & Azage, M. (2015). Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, Northwest Ethiopia: A cross-sectional study. BMC Infectious Diseases, 15(1), 30. https://doi.org/10.1186/s12879-015-0756-8
Abiola, A. O., Omoyeni, O. E., & Akodu, B. A. (2013). Knowledge, attitude and practice of hepatitis B vaccination among health workers at the Lagos State Accident and Emergency Centre, Toll-Gate, Alausa, Lagos State. West African Journal of Medicine, 32(4), 257–262.
Abiola, A. O., Agunbiade, A. B., Badmos, K. B., & Lesi, A. O. (2016). Prevalence of HBsAg, knowledge, and vaccination practice against viral hepatitis B infection among doctors and nurses in a secondary health care facility in Lagos State, South-Western Nigeria. Pan African Medical Journal, 23, 160. https://doi.org/10.11604/pamj.2016.23.160.8710
Adekanle, O., Ndububa, D. A., Olowookere, S. A., Ijarotimi, O., & Ijadunola, K. T. (2015). Knowledge of hepatitis B virus infection, immunization with hepatitis B vaccine, risk perception, and challenges to control hepatitis among hospital workers in a Nigerian tertiary hospital. Hepatitis Research and Treatment, 2015, Article 439867. https://doi.org/10.1155/2015/439867
Aiges, H. (1985). Chronic hepatitis. Pediatric Annals, 14(6). https://doi.org/10.3928/0090-4481-19850601-07
Ajuwon, B. I., Yujuico, I., Roper, K., Richardson, A., Sheel, M., & Lidbury, B. A. (2021). Hepatitis B virus infection in Nigeria: A systematic review and meta-analysis of data published between 2010 and 2019. BMC Infectious Diseases, 21(1), 1120. https://doi.org/10.1186/S12879-021-06800-6
Akibu, M., Nurgi, S., Tadese, M., & Tsega, W. D. (2018). Attitude and vaccination status of healthcare workers against hepatitis B infection in a teaching hospital, Ethiopia. Scientifica, 2018, Article 6705305. https://doi.org/10.1155/2018/6705305
Alege, J. B., Gulom, G., Ochom, A., & Kaku, V. E. (2020). Assessing level of knowledge and uptake of hepatitis B vaccination among health care workers at Juba Teaching Hospital, Juba City, South Sudan. Advances in Preventive Medicine, 2020, Article 8888409. https://doi.org/10.1155/2020/8888409
Alhowaish, M. A., Alhowaish, J. A., Alanazi, Y. H., Alshammari, M. M., Alshammari, M. S., Alshamari, N. G., Alshammari, A. S., Almutairi, M. K., & Algarni, S. A. (2017). Knowledge, attitudes and practices toward prevention of hepatitis B virus infection among medical students at Northern Border University, Arar, Kingdom of Saudi Arabia. Electronic Physician, 9(9), 5388–5394.
Alter, H. J., Seeff, L. B., Kaplan, P. M., McAuliffe, V. J., Wright, E. C., Gerin, J. L., Purcell, R. H., Holland, P. V., & Zimmerman, H. J. (1976). Type B hepatitis: The infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. The New England Journal of Medicine, 295(17), 909–913. https://doi.org/10.1056/NEJM197610212951701
Alward, W. L. M., McMahon, B. J., Hall, D. B., Heyward, W. L., Francis, D. P., & Bender, T. R. (1985). The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. The Journal of Infectious Diseases, 151(4), 604–609. https://doi.org/10.1093/infdis/151.4.604
Amarapurkar, D. N., & Amarapurkar, A. D. (2002). Extrahepatic manifestations of viral hepatitis. Annals of Hepatology, 1(4), 192–195.
André, F. E. (1990). Overview of a 5-year clinical experience with a yeast-derived hepatitis B vaccine. Vaccine, 8(Suppl. 1), S74–S78. https://doi.org/10.1016/0264-410X(90)90222-8
Aniaku, J. K., Amedonu, E. K., & Fusheini, A. (2019). Assessment of knowledge, attitude and vaccination status of hepatitis B among nursing training students in Ho, Ghana. Annals of Global Health, 85(1), 1–9. https://doi.org/10.5334/aogh.750
Auta, A., Adewuyi, E. O., Kureh, G. T., Onoviran, N., & Adeloye, D. (2018). Hepatitis B vaccination coverage among health-care workers in Africa: A systematic review and meta-analysis. Vaccine, 36(32), 4851–4860. https://doi.org/10.1016/j.vaccine.2018.06.043
Awoke, N., Mulgeta, H., Lolaso, T., & Tekalign, T. (2020). Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis. PLoS ONE, 15(11), e0241226. https://doi.org/10.1371/journal.pone.0241226
Barker, L. F., Almeida, J. D., Hoofnagle, J. H., Gerety, R. J., Jackson, D. R., & McGrath, P. P. (1974). Hepatitis B core antigen: Immunology and electron microscopy. Journal of Virology, 14(6), 1552–1558. https://doi.org/10.1128/jvi.14.6.1552-1558.1974
Bedaso, A., Duko, B., & Fedlu, R. (2018). Knowledge on HBV vaccine and vaccination status among health care workers of Hawassa University Comprehensive Specialized Hospital, Hawassa, Southern Ethiopia: A cross-sectional study. BMC Research Notes, 11(1), 1–5. https://doi.org/10.1186/S13104-018-4023-0
Bert, N. L., Gill, U. S., Hong, M., Kunasegaran, K., Tan, D. Z. M., Ahmad, R., Cheng, Y., et al. (2020). Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection. Gastroenterology, 159(2), 652–664. https://doi.org/10.1053/j.gastro.2020.04.019
Biswas, R., Tabor, E., Hsia, C. C., Wright, D. J., Laycock, M. E., Fiebig, E. W., Peddada, L., et al. (2003). Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection. Transfusion, 43(6), 788–798. https://doi.org/10.1046/J.1537-2995.2003.00424.X
Blumberg, B. S. (1997). Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proceedings of the National Academy of Sciences of the United States of America, 94(14), 7121–7125. https://doi.org/10.1073/pnas.94.14.7121
Bond, W. W., Favero, M. S., Petersen, N. J., Gravelle, C. R., Ebert, J. W., & Maynard, J. E. (1981). Survival of hepatitis B virus after drying and storage for one week. The Lancet, 317(8219), 550–551. https://doi.org/10.1016/S0140-6736(81)92877-4
Bruix, J., & Sherman, M. (2005). Management of hepatocellular carcinoma. Hepatology, 42(5), 1208–1236. https://doi.org/10.1002/hep.20933
Burls, A., Jordan, R., Barton, P., Olowokure, B., Wake, B., Albon, E., & Hawker, J. (2006). Vaccinating healthcare workers against influenza to protect the vulnerable—Is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine, 24(19), 4212–4221. https://doi.org/10.1016/j.vaccine.2005.12.043
Buster, E. H. C. J., Hansen, B. E., Lau, G. K. K., Piratvisuth, T., Zeuzem, S., Steyerberg, E. W., & Janssen, H. L. A. (2009). Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology, 137(6), 2002–2009. https://doi.org/10.1053/j.gastro.2009.08.061
Cacoub, P., & Asselah, T. (2022). Hepatitis B virus infection and extra-hepatic manifestations: A systemic disease. The American Journal of Gastroenterology, 117(2), 253–263. https://doi.org/10.14309/AJG.0000000000001575
Calisti, G., Herman, O., Powley, M., & Haque, T. (2014). Persistence of hepatitis B surface antigen in blood in a chronic haemodialysis patient following vaccination booster. BMJ Case Reports, 2014, bcr2013202191. https://doi.org/10.1136/bcr-2013-202191
Caviglia, G. P., Abate, M. L., Noviello, D., Olivero, A., Rosso, C., Troshina, G., Ciancio, A., Rizzetto, M., Saracco, G. M., & Smedile, A. (2017). Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated interferon-α. Hepatology Research, 47(8), 747–754. https://doi.org/10.1111/hepr.12811
Centers for Disease Control and Prevention. (2017). Viral hepatitis—Statistics and surveillance. U.S. Department of Health and Human Services.
Centers for Disease Control and Prevention. (2023). Global viral hepatitis: Millions of people are affected. https://www.cdc.gov/hepatitis/global/
Coppola, N., De Pascalis, S., Onorato, L., Calò, F., Sagnelli, C., & Sagnelli, E. (2016). Hepatitis B virus and hepatitis C virus infection in healthcare workers. World Journal of Hepatology, 8(5), 273–281. https://doi.org/10.4254/wjh.v8.i5.273
Cui, F., Faini, D., Razavi-Shearer, D., Razavi, H., Manzengo Mingiedi, C., Gonzalez, M. A., Alaama, A. S., Mozalevskis, A., Chan, P., Izumi, K., Ghrabi, M. A., Doherty, M., Olufunmilayo, L., Luhmann, N., de Martel, C., Dirac, M., Hallett, T. B., Nayagam, S., Vickerman, P., & Low-Beer, D. (2026). The burden of chronic hepatitis B and C in 2022 and progress towards elimination: A global report. The Lancet Gastroenterology & Hepatology, 11(6), 509–520. https://doi.org/10.1016/S2468-1253(25)00375-9
Das, S., Ramakrishnan, K., Behera, S. K., Ganesapandian, M., Xavier, A. S., & Selvarajan, S. (2019). Hepatitis B vaccine and immunoglobulin: Key concepts. Journal of Clinical and Translational Hepatology, 7(2), 165–171. https://doi.org/10.14218/JCTH.2018.00037
Dayyab, F. M., Iliyasu, G., Ahmad, B. G., Bako, A. T., Ngamariju, S. S., & Habib, A. G. (2020). Hepatitis B vaccine knowledge and self-reported vaccination status among healthcare workers in a conflict region in Northeastern Nigeria. Therapeutic Advances in Vaccines and Immunotherapy, 8, 2515135519900743. https://doi.org/10.1177/2515135519900743
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019). Therapeutic strategies for hepatitis B virus infection: Towards a cure. Nature Reviews Drug Discovery, 18(11), 827–844. https://doi.org/10.1038/s41573-019-0037-0
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer, 136(5), E359–E386. https://doi.org/10.1002/ijc.29210
Galanakis, E., Jansen, A., Lopalco, P. L., & Giesecke, J. (2013). Ethics of mandatory vaccination for healthcare workers. Eurosurveillance, 18(45), 20627. https://doi.org/10.2807/1560-7917.ES2013.18.45.20627
Gane, E., Verdon, D. J., Brooks, A. E., Gaggar, A., Nguyen, A. H., Subramanian, G. M., Schwabe, C., & Dunbar, P. R. (2019). Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study. Journal of Hepatology, 71(5), 900–907. https://doi.org/10.1016/j.jhep.2019.06.028
Gebremariam, A. A., Tsegaye, A. T., Shiferaw, Y. F., Reta, M. M., & Getaneh, A. (2019). Seroprevalence of hepatitis B virus and associated factors among health professionals in University of Gondar Hospital, Northwest Ethiopia. Journal of Environmental and Public Health, 2019, Article 7136763. https://doi.org/10.1155/2019/7136763
Gish, R. G., Basit, S. A., Ryan, J., Dawood, A., & Protzer, U. (2020). Hepatitis B core antibody: Role in clinical practice in 2020. Current Hepatology Reports, 19(3), 254–265. https://doi.org/10.1007/s11901-020-00522-0
Grob, P., Jilg, W., Bornhak, H., Gerken, G., Gerlich, W., Günther, S., Hess, G., et al. (2000). Serological pattern “anti-HBc alone”: Report on a workshop. Journal of Medical Virology, 62(4), 450–455. https://doi.org/10.1002/1096-9071(200012)62:4<450::AID-JMV9>3.0.CO;2-Y
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010). Intrinsic antibody-dependent enhancement of microbial infection in macrophages: Disease regulation by immune complexes. The Lancet Infectious Diseases, 10(10), 712–722. https://doi.org/10.1016/S1473-3099(10)70166-3
Hang, T. T., Le, T. X., Nguyen, D. T., Luu, C. M., Truong, B. D., Tran, P. D., Toy, M., Bozkurt, S., & So, S. (2019). Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. PLoS ONE, 14(10), e0223733. https://doi.org/10.1371/journal.pone.0223733
Honda, M., Shirasaki, T., Terashima, T., Kawaguchi, K., Nakamura, M., Oishi, N., Wang, X., et al. (2015). Hepatitis B virus (HBV) core-related antigen during nucleos(t)ide analog therapy is related to intrahepatic HBV replication and development of hepatocellular carcinoma. The Journal of Infectious Diseases, 213(1), 109–118. https://doi.org/10.1093/infdis/jiv572
Huang, X., & Hollinger, F. B. (2014). Occult hepatitis B virus infection and hepatocellular carcinoma: A systematic review. Journal of Viral Hepatitis, 21(3), 153–162. https://doi.org/10.1111/jvh.12222
Hudcova, J., Ruthazer, R., Bonney, I., & Schumann, R. (2014). Sodium homeostasis during liver transplantation and correlation with outcomes. Anesthesia & Analgesia, 119(6), 1420–1428. https://doi.org/10.1213/ANE.0000000000000415
Hunachew, M., & Biruck, Y. (2014). Occupational risk factors associated with needle-stick injury among healthcare workers in Hawassa City, Southern Ethiopia. Occupational Medicine & Health Affairs, 2, 156.
Iannacone, M., & Guidotti, L. G. (2022). Immunobiology and pathogenesis of hepatitis B virus infection. Nature Reviews Immunology, 22(1), 19–32. https://doi.org/10.1038/S41577-021-00549-4
Jeng, W. J., Sheen, I. S., Chen, Y. C., Hsu, C. W., Chien, R. N., Chu, C. M., & Liaw, Y. F. (2013). Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients. Hepatology, 58(6), 1888–1896. https://doi.org/10.1002/hep.26549
Ji, C., & Maayan, S. (1981). The bacteremic patient as a source of infection. The New England Journal of Medicine, 305(10), 582–583. https://doi.org/10.1056/NEJM198109033051017
Jo, Y., Labrique, A. B., Lefevre, A. E., Mehl, G., Pfaff, T., Walker, N., & Friberg, I. K. (2014). Using the Lives Saved Tool (LiST) to model mHealth impact on neonatal survival in resource-limited settings. PLoS ONE, 9(7), e102224. https://doi.org/10.1371/journal.pone.0102224
Ogoina, D., Pondei, K., Adetunji, B., Chima, G., Isichei, C., & Gidado, S. (2014). Prevalence of hepatitis B vaccination among health care workers in Nigeria in 2011–2012. International Journal of Occupational and Environmental Medicine, 5(1), 51–56.
World Health Organization. (2016). Global health sector strategy on viral hepatitis 2016–2021: Towards ending viral hepatitis. https://www.who.int/publications/i/item/WHO-HIV-2016.06
World Health Organization. (2025). Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
World Health Organization. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. World Health Organization